Vertex's diverse pipeline positions it for a growth, despite challenges in launching new drugs like Casgevy and suzetrigine.

All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for drug development and identify potential effective ...

Researchers obtain detailed picture of the specific mechanisms by which each individual mutation studied impacts drug response.

The virus, which is transmitted via insect bite, seems to be reaching new areas, undergoing genetic changes, and may harm ...

In the debate over artificial general intelligence, it’s often the “doomers” ( Eliezer Yudkowsky) or showmen (OpenAI CEO Sam ...

IQ EQ FUND MANAGEMENT IRELAND Ltd lifted its position in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 30.7% during the ...

The $5.3m seed funding will enable clock.bio to develop its atlas of rejuvenation factors and will also enable next steps in ...

A multi-institutional group of researchers led by the Hubrecht Institute and Roche's Institute of Human Biology has developed ...

Boston, Massachusetts-based Vertex Pharmaceuticals Incorporated (VRTX) develops and commercializes therapies for treating ...

Cambridge scientists and collaborators have mapped drug resistance across different cancers, highlighted DNA changes that may ...